The store will not work correctly when cookies are disabled.
(E)-N1-[[3-(4-Fluorophenyl)-1H-pyrazol-4-yl]methylene]-N4,N4-dimethylbenzene-1,4-diamine
ID: ALA4472534
PubChem CID: 155535370
Max Phase: Preclinical
Molecular Formula: C18H17FN4
Molecular Weight: 308.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1ccc(/N=C/c2c[nH]nc2-c2ccc(F)cc2)cc1
Standard InChI: InChI=1S/C18H17FN4/c1-23(2)17-9-7-16(8-10-17)20-11-14-12-21-22-18(14)13-3-5-15(19)6-4-13/h3-12H,1-2H3,(H,21,22)/b20-11+
Standard InChI Key: LPIAZFVJRVLOKG-RGVLZGJSSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
3.9648 -2.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9637 -3.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6717 -3.7048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3814 -3.2954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3786 -2.4727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6700 -2.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6739 -4.5183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0127 -4.9985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2650 -5.7757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0822 -5.7759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3348 -4.9988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6675 -1.2503 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.1121 -4.7464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7193 -5.2933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4965 -5.0410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1005 -5.5906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8771 -5.3388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0478 -4.5388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4357 -3.9910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6614 -4.2457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8247 -4.2854 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4326 -4.8315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9937 -3.4858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
11 7 1 0
3 7 1 0
6 12 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
21 22 1 0
21 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.36 | Molecular Weight (Monoisotopic): 308.1437 | AlogP: 4.03 | #Rotatable Bonds: 4 |
Polar Surface Area: 44.28 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.23 | CX LogP: 4.44 | CX LogD: 4.44 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.74 | Np Likeness Score: -1.94 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |